Fraser, J. F., Spooner, A. J., Dunster, K. R., Anstey, C. M., & Corley, A. (2016). Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: A randomised crossover trial. Thorax.
Citação norma ChicagoFraser, John F., Amy J. Spooner, Kimble R. Dunster, Chris M. Anstey, and Amanda Corley. "Nasal High Flow Oxygen Therapy in Patients With COPD Reduces Respiratory Rate and Tissue Carbon Dioxide While Increasing Tidal and End-expiratory Lung Volumes: A Randomised Crossover Trial." Thorax 2016.
MLA citiranjeFraser, John F., et al. "Nasal High Flow Oxygen Therapy in Patients With COPD Reduces Respiratory Rate and Tissue Carbon Dioxide While Increasing Tidal and End-expiratory Lung Volumes: A Randomised Crossover Trial." Thorax 2016.